Omics-oriented research illustrated with the LEAP study and the OASIS bioinformatics tool - 03/02/23
Doi : 10.1016/j.jaci.2022.12.003
Carolyn H. Baloh, MD a, b, Kanika Kanchan, PhD c, Gautam Shankar, MS c, Gerald T. Nepom, MD, PhD a, d, Rasika A. Mathias, ScD c, ⁎ 
, James A. Perry, PhD e
, James A. Perry, PhD e a The Immune Tolerance Network, Benaroya Research Institute at Virginia Mason, Seattle, Wash
b Department of Medicine, Harvard Medical School, Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital, Boston, Mass
c Department of Medicine, School of Medicine, Johns Hopkins University, Division of Allergy and Clinical Immunology, Baltimore, Md
d Benaroya Research Institute at Virginia Mason, Seattle, Wash
e Department of Medicine, University of Maryland School of Medicine, Baltimore, Md
∗Corresponding author: Rasika Mathias, ScD, 5501 Hopkins Bayview Circle, Baltimore, MD 21224.5501 Hopkins Bayview CircleBaltimoreMD21224
Key words : Peanut allergy, food allergy, allergy prevention, genetics, genomics, genome-wide association study, GWAS, mucosa-associated lymphoid tissue lymphoma translocation gene, MALT1 gene, bioinformatic tool(s)
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| This research was performed as a project of the Immune Tolerance Network, an international clinical research consortium headquartered at the Benaroya Research Institute, and supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (award UM1AI109565). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2022
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 151 - N° 2
P. 416-419 - febbraio 2023 Ritorno al numero
Articolo precedente
- Management of patients with immediate reactions to COVID-19 vaccines
- Matthieu Picard, Cosby A. Stone, Matthew Greenhawt
- Neutrophilic asthma at an inhibitory checkpoint: A PD-1–targeted approach
- Nyssa B. Samanas, Ryan C. Murphy, Irina Miralda, Teal S. Hallstrand, Adrian M. Piliponsky
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?